PRESS RELEASE published on 05/23/2023 at 22:45, 3 years 5 months ago Redishred Capital Corp. ("Redishred") To Announce 1st Quarter 2023 Results At Its Annual General Meeting With Follow Up On Investor Conference Call
PRESS RELEASE published on 05/04/2023 at 22:31, 3 years 6 months ago Redishred Capital Corp. ("Redishred", Or The "Company") Announces Normal Course Issuer Bid for Its Shares
PRESS RELEASE published on 04/22/2023 at 02:45, 3 years 6 months ago Redishred Capital Corp. ("Redishred", or the "Company") Announces Q4 and Fiscal 2022 Results, Consolidated EBITDA Grew 67% and Same Corporate Location EBITDA Grew 39% Compared to 2021
PRESS RELEASE published on 04/18/2023 at 22:05, 3 years 6 months ago Redishred Capital Corp. (“Redishred”) to Announce Fourth Quarter and Year Ended 2022 Results, and Investor Conference Call Details
PRESS RELEASE published on 03/31/2023 at 23:55, 3 years 7 months ago Redishred Capital Corp. Announces New Stock Option Grants
PRESS RELEASE published on 02/06/2023 at 22:05, 3 years 8 months ago Redishred Capital Corp. Announces New Stock Option Grants
Published on 11/04/2026 at 23:10, 3 hours 4 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 3 hours 14 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 59 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 4 hours 9 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 2 hours 11 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 6 hours 32 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 48 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 7 hours 31 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 8 hours 8 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 8 hours 13 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 8 hours 13 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 8 hours 30 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
